Experimental drug that boosts immunotherapy shows promise in bladder cancer study

Researchers have found adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in mice. This approach shows such promise that it's already being tested in an ongoing clinical trial in people with advanced bladder cancer.

source https://www.sciencedaily.com/releases/2021/08/210816125723.htm